Table 3.
Relative risk (RR) estimates and 95% credible intervals (95% CrI) for the association between IC condition and HZ incidence, HZ-complications and HZ recurrence, controlling by sex, age, comorbidities (COPD, diabetes, HF and CKD), health department (as a random effect) and calendar year, using Bayesian Poisson regression
| aHZ RR (95% CrI) |
bHZ-Complications RR (95% CrI) |
bHZ-Recurrence RR (95% CrI) |
||
|---|---|---|---|---|
| IC | IC-free | 1 | 1 | 1 |
| IC | 1.51 (1.48–1.54) | 2.37 (2.01–2.8) | 1.25 (1.19–1.31) | |
| SEX | Man | 1 | 1 | 1 |
| Woman | 1.33 (1.31–1.35) | 1.15 (0.98–1.35) | 1.19 (1.14–1.24) | |
| AGE | 18–29 | 1 | 1 | 1 |
| 30–39 | 1.06 (1.02–1.09) | 5.62 (2.63–11.99) | 1.08 (0.95–1.23) | |
| 40–49 | 1.24 (1.2–1.29) | 9.71 (4.9–19.24) | 1.14 (1.01–1.28) | |
| 50–59 | 2.42 (2.35–2.5) | 7.74 (3.95–15.16) | 1.21 (1.08–1.36) | |
| 60–69 | 3.43 (3.32–3.54) | 12.3 (6.84–22.1) | 1.52 (1.36–1.7) | |
| 70–79 | 3.72 (3.61–3.85) | 26.14 (14.72–46.44) | 1.9 (1.7–2.12) | |
| ≥ 80 | 3.57 (3.45–3.7) | 39.72 (22.5–70.12) | 2.14 (1.91–2.4) | |
| COMORBIDITIES | ||||
| COPD | NO-COPD | 1 | 1 | 1 |
| COPD | 1.36 (1.32–1.4) | 2.54 (2.11–3.06) | 1.26 (1.17–1.35) | |
| DIABETES | NO-DIABETES | 1 | 1 | 1 |
| DIABETES | 1.12 (1.09–1.14) | 1.07 (0.89–1.28) | 1.05 (1–1.11) | |
| HF | NO-HF | 1 | 1 | 1 |
| HF | 1.16 (1.11–1.21) | 2.07 (1.68–2.55) | 1.63 (1.39–1.9) | |
| CKD | NO-CKD | 1 | 1 | 1 |
| CKD | 1.18 (1.13–1.23) | 1.63 (1.31–2.03) | 1.2 (1.09–1.33) | |
aA Quasi poisson regression model adjusted by sex, age, calendar year, health department and comorbidities (COPD, diabetes, HF and CKD) was used to estimate the risk of HZ in IC respect to IC-free subjects
bA Zero-inflated negative binomial model adjusted by sex, age, calendar year, health department and comorbidities (COPD, diabetes, HF and CKD) was used to estimate the risk of HZ complications (based on hospitalization diagnoses) and recurrence in IC respect to IC-free